129 related articles for article (PubMed ID: 16112475)
1. Localization of alpha-synuclein to identified fibers and synapses in the normal mouse brain.
Totterdell S; Meredith GE
Neuroscience; 2005; 135(3):907-13. PubMed ID: 16112475
[TBL] [Abstract][Full Text] [Related]
2. The ultrastructural distribution of alpha-synuclein-like protein in normal mouse brain.
Totterdell S; Hanger D; Meredith GE
Brain Res; 2004 Apr; 1004(1-2):61-72. PubMed ID: 15033420
[TBL] [Abstract][Full Text] [Related]
3. Different sub-cellular localization of alpha-synuclein in the C57BL\6J mouse's central nervous system by two novel monoclonal antibodies.
Vivacqua G; Casini A; Vaccaro R; Fornai F; Yu S; D'Este L
J Chem Neuroanat; 2011 Mar; 41(2):97-110. PubMed ID: 21172422
[TBL] [Abstract][Full Text] [Related]
4. Perivascular nerve fiber α-synuclein regulates contractility of mouse aorta: a link to autonomic dysfunction in Parkinson's disease.
Marrachelli VG; Miranda FJ; Alabadí JA; Milán M; Cano-Jaimez M; Kirstein M; Alborch E; Fariñas I; Pérez-Sánchez F
Neurochem Int; 2010 Jul; 56(8):991-8. PubMed ID: 20420875
[TBL] [Abstract][Full Text] [Related]
5. Semi-quantitative analysis of alpha-synuclein in subcellular pools of rat brain neurons: an immunogold electron microscopic study using a C-terminal specific monoclonal antibody.
Zhang L; Zhang C; Zhu Y; Cai Q; Chan P; Uéda K; Yu S; Yang H
Brain Res; 2008 Dec; 1244():40-52. PubMed ID: 18817762
[TBL] [Abstract][Full Text] [Related]
6. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
Schell H; Hasegawa T; Neumann M; Kahle PJ
Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424
[TBL] [Abstract][Full Text] [Related]
7. Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in alpha-synuclein knockout and A30P transgenic mice.
Yavich L; Jäkälä P; Tanila H
J Neurochem; 2006 Nov; 99(3):724-32. PubMed ID: 16824047
[TBL] [Abstract][Full Text] [Related]
8. Decreased alpha-synuclein expression in the aging mouse substantia nigra.
Mak SK; McCormack AL; Langston JW; Kordower JH; Di Monte DA
Exp Neurol; 2009 Dec; 220(2):359-65. PubMed ID: 19800328
[TBL] [Abstract][Full Text] [Related]
9. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology.
Braak H; de Vos RA; Bohl J; Del Tredici K
Neurosci Lett; 2006 Mar; 396(1):67-72. PubMed ID: 16330147
[TBL] [Abstract][Full Text] [Related]
10. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
Chu Y; Kordower JH
Neurobiol Dis; 2007 Jan; 25(1):134-49. PubMed ID: 17055279
[TBL] [Abstract][Full Text] [Related]
11. Human-based studies on alpha-synuclein deposition and relationship to Parkinson's disease symptoms.
Halliday GM; McCann H
Exp Neurol; 2008 Jan; 209(1):12-21. PubMed ID: 17706644
[TBL] [Abstract][Full Text] [Related]
12. Role of alpha-synuclein in synaptic glutamate release.
Gureviciene I; Gurevicius K; Tanila H
Neurobiol Dis; 2007 Oct; 28(1):83-9. PubMed ID: 17689254
[TBL] [Abstract][Full Text] [Related]
13. Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody.
Yu S; Li X; Liu G; Han J; Zhang C; Li Y; Xu S; Liu C; Gao Y; Yang H; Uéda K; Chan P
Neuroscience; 2007 Mar; 145(2):539-55. PubMed ID: 17275196
[TBL] [Abstract][Full Text] [Related]
14. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
Gallardo G; Schlüter OM; Südhof TC
Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
[TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP.
Kim S; Cho SH; Kim KY; Shin KY; Kim HS; Park CH; Chang KA; Lee SH; Cho D; Suh YH
J Neurochem; 2009 Jun; 109(5):1483-96. PubMed ID: 19457162
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
Alvarez-Fischer D; Henze C; Strenzke C; Westrich J; Ferger B; Höglinger GU; Oertel WH; Hartmann A
Exp Neurol; 2008 Mar; 210(1):182-93. PubMed ID: 18053987
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
Lee VM; Trojanowski JQ
Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225
[TBL] [Abstract][Full Text] [Related]
18. Intragastric proteasome inhibition induces alpha-synuclein-immunopositive aggregations in neurons in the dorsal motor nucleus of the vagus in rats.
Miwa H; Kubo T; Suzuki A; Kondo T
Neurosci Lett; 2006 Jun; 401(1-2):146-9. PubMed ID: 16600504
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D2 receptor knockout mice develop features of Parkinson disease.
Tinsley RB; Bye CR; Parish CL; Tziotis-Vais A; George S; Culvenor JG; Li QX; Masters CL; Finkelstein DI; Horne MK
Ann Neurol; 2009 Oct; 66(4):472-84. PubMed ID: 19847912
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity.
Kontopoulos E; Parvin JD; Feany MB
Hum Mol Genet; 2006 Oct; 15(20):3012-23. PubMed ID: 16959795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
